Blog Posts in October, 2017
-
AbbieVie Suffers a Second Verdict Against AndroGel®
Posted By Brett H. Oppenheimer, PLLC$140 Million Verdict Against AbbieVie in “Low T” Trial Jurors returned a $140 million verdict for the plaintiff in the latest testosterone (“Low T”) trial against manufacturer, AbbVie in October of 2017. The plaintiff had used Androgel® for two months prior to experiencing a heart attack. He sued AbbieVie in 2015. This is the second straight verdict against AbbieVie’s Androgel®, a testosterone ...Continue Reading
Page
1 of 1